Portfolio Planning & Pipeline Optimization

Better understanding of your therapy landscape provides you a good chance to develop your prospect towards amazing journey of approval and launch, and it also allows you to differentiate yourself in the market.

Our Pipeline Assessment support provides you a detailed insights on different therapies, drugs, mode of action, APIs, and product launch planning of drugs who are in middle and late-stage of development and will give you a better understanding of the competitors’ development strategies and estimated launch timelines. We provide detailed profiling of assets, comparative therapeutic assessment, cross analysis of the assets with the history of regulatory and IP filling (preliminary and detailed IPR analysis).

Clinical Trials produces huge data sets from different portfolio across multiple sites globally, the data generated need to have analyzed properly in order to build a comprehensive view for making informed decisions however, companies struggle in functionalizing the data hence hours and multiple resources are utilized to collect and interpret it.

eQuantX Clinical Trial Analytics Platform support you by providing end to end study review, site with extended support with program level metrics for making data driven decisions in improving clinical operations and help bringing the product faster to market

As a company, you should always upgrade and elevate your strategies to reduce the gaps in your portfolio and make the decision whether to buy or develop it. Your assets should be checked with competitors' pipelines and identify which asset is suitable for portfolio expansion.

Our solutions on portfolio strategy provide you an accurate and timely intelligence includes comprehensive and updated coverage of companies, drugs, diseases, epidemiology, strategy, reimbursement, and pricing trends, patients and sales-based forecasting and survey with top physicians/KOL's based on indications, country-specific reimbursement and current treatment scenario on a timely basis which will help you to understand key insights and macro and micro trends for commercial decisions

Our long range revenue forecasting is a continuous process that will provide you to regular monitoring and make adjustment in your forecasts periodically and update them based on updated information, news alerts, feedback, or changes in your business environment. You will also be able to track your actual revenue against your forecasts and analyze the variance and the reasons behind it. This will help you improve your forecasting accuracy and reliability over time.

The patient-based sales forecasting needs a driver-based approach involving statistical methods to forecast the sales in different therapeutic areas. We help and develop models which forecast the eligible number of patients and are translated into volume using prevalence or incidence-based patient models. We use The 4 steps in Patient-based sales forecasting: Epidemiology and Segmentation, Value Derivation, Applying Penetration Rate & Patient Share, and Projecting Sales.

Differentiating your platform & asset, defining opportunities, and presenting value beyond the standard of care is vital, and it has become increasingly complex and challenging in terms of competition.

eQuantX not only guides you in development and commercial strategy we explore for you with the real-world insights and will provide the robust strategies across the lifecycle from innovation to commercialization of your assets

Providing a 360-degree view of your landscape, guiding you through the intricacies of market appraisal, competition analysis, and market access. We evaluate the clinical viability and commercial potential of your assets through commercial and scientific due diligence, enabling you to make informed decisions on partnerships and acquisitions.

From rapid assessments to comprehensive due diligence, our capabilities seamlessly provide the information you need at every stage of your journey in identifying potential partners, M&A targets, and licensing opportunities through scenario planning and transaction diligence.

New product launch takes lots of effort and demands a major investment from the existing revenue and profit of a company. We ensure a successful launch in new markets and provide Market access strategy, and a competitive landscape to tackle competition.

Furthermore, our approach goes beyond the initial launch phase. We stay by your side to monitor the product's performance, making necessary adjustments and enhancements to ensure its continued success in the ever-evolving market. Whether it's evaluating market trends, optimizing distribution channels, or refining your marketing approach, we are here to support your product's journey from inception to sustained growth.

Our Go-to-Market (GTM) strategy primarily aims to ensure a successful product launch by defining plans and directions across all functional areas. It focuses on reducing time-to-market, understanding the patient's journey, minimizing costs associated with incorrect assumptions or product launch failures, ensuring regulatory compliance, crafting effective pricing strategies, identifying marketing tactics, allocating budgets for launch activities, and enhancing adaptability to market changes.

eQuantX design and implement effective GTM strategy by considering factors such as having the right competencies and functions, understanding therapeutic area trends and key stakeholders, mapping the patient journey, evaluating market potential, and conducting global pricing analysis and strategy, to meet the broader objectives of our client.